Apellis Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Crestwood KY United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02264639
First Marketed Drug
2021
pegcetacoplan
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Apellis Pharmaceuticals, Inc. | APELLIS PHARMS